E. Bilgin Et Al. , "Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2, 2021
Bilgin, E. Et Al. 2021. Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2 .
Bilgin, E., Oral, H., Damadoglu, E., & Karadag, O., (2021). Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2.
Bilgin, E. Et Al. "Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2, 2021
Bilgin, E. Et Al. "Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2, 2021
Bilgin, E. Et Al. (2021) . "Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.2.
@article{article, author={E. Bilgin Et Al. }, title={Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2021}